Fatroximin Dry Cow, 100 mg/5ml intramammaarsalv kinnislehmadele
Fatroximin Dry Cow, 100 mg/5ml intramammaarsalv kinnislehmadele
Authorised
- Rifaximin
Product identification
Medicine name:
Fatroximin Dry Cow, 100 mg/5ml intramammaarsalv kinnislehmadele
Active substance:
- Rifaximin
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (dry cow)
-
Meat and offal0dayMitte tarvitada ravitud loomade udarat inimtoiduks.
-
Milk0day0 päeva, kui kinnisperiood on pikem kui 42 päeva; 15 lüpsikorda, kui kinnisperiood on lühem kui 42 päeva.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51XX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1110
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 19/01/2022
How useful was this page?:
